Composition for treating upper respiratory inflammatory infection, and preparation method of composition

Abstract

The invention provides a composition for treating upper respiratory inflammatory infection, and a preparation method of the composition. The composition is prepared from the following raw materials inparts by weight: 500-3000 parts of cranberry, 500-2000 parts of bamboo leaf flavonoid, 100-800 parts of liquorice root, 100-800 parts of fructus momordicae, 100-800 parts of pineapple, 100-800 partsof green kumquat, 100-800 parts of xylitol, 200-1000 parts of lily bulb, 100-600 parts of herba houttuyniae, 50-200 parts of herba menthae, 50-200 parts of flos chrysanthemi, 50-200 parts of honeysuckle flower, 10-100 parts of rhizoma zingiberis recens, 10-100 parts of folium eriobotryae, 10-100 parts of radix platycodon, 10-100 parts of noni fruit, 1-50 parts of elderberry, 1-50 parts of herba taraxaci and 5-20 parts of sucralose. The preparation method comprises the steps of grinding all the raw materials, screening the ground materials and then mixing. The composition provided by the invention not only can eliminate and prevent various inflammations, especially the inflammation caused by upper respiratory infection, but also can improve body immunity and repair ability, is delicious andpure in taste, natural and nutritional, thus being suitable for being taken for a long time.

Description

technical field [0001] The invention relates to the technical field of pure natural plant compositions, in particular to a composition for treating upper respiratory tract inflammation and infection and a preparation method thereof. Background technique [0002] Anti-inflammatory drugs are used to treat inflammation that occurs after tissue damage. There are two categories of anti-inflammatory drugs: one is steroidal anti-inflammatory drugs, namely the glucocorticoid hydrocortisone and its synthetic derivatives secreted by the adrenal cortex; the other is non-steroidal anti-inflammatory drugs (NSAIDs, non-steroid-anti-inflammatory drugs), that is, antipyretic, analgesic and anti-inflammatory drugs such as aspirin, phenylbutazone, celecoxib, etc. referred to in medical practice. [0003] At present, most of the anti-inflammatory drugs on the market for the treatment of upper respiratory tract inflammatory infections are Western medicines. Most of these anti-inflammatory drug...

AI Technical Summary

Problems solved by technology

The constituent drug Chansu in this invention is the main active drug that exerts the therapeutic effect of "fighting poison with poison". Although it improves the safety of drug use and achieves the purpose of synergizing and reducing toxicity compared with Jiuxin Pills, Chansu is still a severe drug. Toxic drug, with occasional cases of inadvertent overdose causing poisoning, so the drug is still limited in application to a certain extent

Images